Compounds > mci 9038
Page last updated: 2024-08-26

mci 9038 and Antithrombin III Deficiency

mci 9038 has been researched along with Antithrombin III Deficiency in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19903 (27.27)18.7374
1990's4 (36.36)18.2507
2000's4 (36.36)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agishi, T; Akizawa, T; Hirasawa, Y; Matsui, N; Ota, K1
Eto, T; Gondo, H; Hamasaki, N; Ichimiya, H; Kato, K; Kawamoto, M; Kayamori, Y; Muta, T; Okamura, T; Shibuya, T; Urata, M; Wada, Y; Yamanaka, M1
Brüggener, E; Hauptmann, J; Müller, H1
Mihara, H; Satsuma, J; Yoshihara, H1
Kario, K; Koide, M; Matsuo, T1
Kikumoto, R; Tamao, Y1
Furukawa, K; Hirahara, K; Koga, S; Narita, Y; Ohteki, H1
Gordan, L; Gorman, R; Kitchens, C; Zumberg, M1
Kario, K; Kodama, K; Matsuo, T; Okamoto, S1
Matsuo, M; Matsuo, T; Sakai, R; Yamada, T1
Abiko, Y; Hara, T; Iwamoto, M; Kumada, T; Ogawa, H; Tomikawa, M1

Reviews

3 review(s) available for mci 9038 and Antithrombin III Deficiency

ArticleYear
Application of argatroban, direct thrombin inhibitor, in heparin-intolerant patients requiring extracorporeal circulation.
    Artificial organs, 1997, Volume: 21, Issue:9

    Topics: Anticoagulants; Antithrombin III Deficiency; Antithrombins; Arginine; Contraindications; Extracorporeal Circulation; Granulocytes; Heparin; Humans; Leukocyte Elastase; Pipecolic Acids; Sulfonamides; Thrombocytopenia

1997
Effect of argatroban, a selective thrombin inhibitor, on animal models of cerebral thrombosis.
    Seminars in thrombosis and hemostasis, 1997, Volume: 23, Issue:6

    Topics: Acute Disease; Animals; Anticoagulants; Antithrombin III Deficiency; Antithrombins; Arginine; Disease Models, Animal; Extracorporeal Circulation; Intracranial Embolism and Thrombosis; Pipecolic Acids; Rats; Sulfonamides

1997
Clinical application of the synthetic thrombin inhibitor, argatroban (MD-805).
    Seminars in thrombosis and hemostasis, 1992, Volume: 18, Issue:2

    Topics: Antibodies; Antithrombin III Deficiency; Antithrombins; Arginine; Blood Platelets; Heparin; Heparin Antagonists; Humans; Pipecolic Acids; Renal Dialysis; Sulfonamides; Thrombocytopenia

1992

Other Studies

8 other study(ies) available for mci 9038 and Antithrombin III Deficiency

ArticleYear
Effects of argatroban as an anticoagulant for haemodialysis in patients with antithrombin III deficiency.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18, Issue:8

    Topics: Aged; Anticoagulants; Antithrombin III Deficiency; Arginine; Female; Hematocrit; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pipecolic Acids; Renal Dialysis; Retrospective Studies; Sulfonamides

2003
Successful therapy with argatroban for superior mesenteric vein thrombosis in a patient with congenital antithrombin deficiency.
    European journal of haematology, 2005, Volume: 75, Issue:2

    Topics: Adult; Antithrombin III Deficiency; Arginine; DNA Mutational Analysis; Female; Frameshift Mutation; Heterozygote; Humans; Mesenteric Vascular Occlusion; Mesenteric Veins; Pipecolic Acids; Salvage Therapy; Sulfonamides; Treatment Outcome; Venous Thrombosis

2005
[Substitution of antithrombin III by synthetic thrombin inhibitors].
    Folia haematologica (Leipzig, Germany : 1928), 1984, Volume: 111, Issue:4

    Topics: Animals; Antithrombin III; Antithrombin III Deficiency; Arginine; Carbon Tetrachloride Poisoning; Fibrinogen; Heparin; Phenylpyruvic Acids; Pipecolic Acids; Platelet Count; Rats; Sulfonamides; Thrombin; Thrombosis

1984
[Mathematical simulation of the blood coagulation system].
    Nihon seirigaku zasshi. Journal of the Physiological Society of Japan, 1984, Volume: 46, Issue:4

    Topics: Adult; Anticoagulants; Antithrombin III; Antithrombin III Deficiency; Arginine; Blood Coagulation; Factor VII; Factor VIIa; Hemophilia A; Heparin; Humans; Male; Mathematics; Microcomputers; Models, Biological; Partial Thromboplastin Time; Pipecolic Acids; Prothrombin; Prothrombin Time; Sulfonamides

1984
The use of argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operations.
    The Journal of thoracic and cardiovascular surgery, 2001, Volume: 122, Issue:6

    Topics: Adult; Anticoagulants; Antithrombin III Deficiency; Aortic Valve; Arginine; Cardiopulmonary Bypass; Heart Valve Prosthesis Implantation; Humans; Male; Pipecolic Acids; Sulfonamides

2001
Successful use of argatroban as an anticoagulant in burn-related severe acquired antithrombin III deficiency after heparin failure.
    Thrombosis and haemostasis, 2001, Volume: 86, Issue:6

    Topics: Accidents, Home; Adult; Anticoagulants; Antithrombin III Deficiency; Arginine; Burns; Cardiovascular Agents; Coronary Vasospasm; Debridement; Drug Therapy, Combination; Explosions; Humans; Male; Pipecolic Acids; Sulfonamides; Ventricular Dysfunction, Left; Warfarin

2001
Anticoagulant therapy in a congenital antithrombin III (ATIII)-deficient patient with chronic renal failure undergoing regular hemodialysis.
    Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology, 1991, Volume: 19, Issue:1

    Topics: Adult; Antithrombin III; Antithrombin III Deficiency; Antithrombins; Arginine; Heparin; Humans; Kidney Failure, Chronic; Male; Peptide Hydrolases; Pipecolic Acids; Renal Dialysis; Sulfonamides

1991
[Preventive effects of synthetic antithrombin, MD-805, on animal thrombosis models].
    Rinsho byori. The Japanese journal of clinical pathology, 1987, Volume: Spec No 73

    Topics: Acute Disease; Animals; Antithrombin III Deficiency; Antithrombins; Arginine; Arterial Occlusive Diseases; Mice; Pipecolic Acids; Pulmonary Embolism; Rats; Rats, Inbred Strains; Sulfonamides; Thrombosis; Vena Cava, Inferior

1987